Am Fam Physician. 2024;110(2):207-209
Author disclosure: No relevant financial relationships.
KEY POINTS FOR PRACTICE
• Complicated UTIs caused by resistant Enterobacterales can be treated with TMP/SMX, ciprofloxacin, or levofloxacin. Nitrofurantoin and TMP/SMX are recommended for uncomplicated cystitis.
• Primary treatment of infections due to ESBL-producing Enterobacterales that occur outside the urinary tract is carbapenems.
• Primary treatment of infections due to CRE that occur outside the urinary tract is medication that combines beta-lactams and beta-lactamase inhibitors.
• Primary treatment of Pseudomonas aeruginosa infections with difficult-to-treat resistance includes ceftolozane/tazobactam, ceftazidime/avibactam, imipenem/cilastatin/relebactam, or cefiderocol.
From the AFP Editors
Antimicrobial resistance is a global crisis, and resistant pathogens cause more than 2.8 million infections and 35,000 deaths annually. Even when bacterial cultures indicate resistance, choosing the most effective antibiotic can be challenging. The Infectious Diseases Society of America published guidelines for treating infections with the most common resistant gram-negative organisms. These guidelines do not apply to empiric treatment.
Subscribe
From $165- Immediate, unlimited access to all AFP content
- More than 130 CME credits/year
- AAFP app access
- Print delivery available
Issue Access
$59.95- Immediate, unlimited access to this issue's content
- CME credits
- AAFP app access
- Print delivery available
